bromodeoxyuridine has been researched along with Adenocarcinoma Of Kidney in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 6 (54.55) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aguirre, MV; Albert, PS; Alotti, N; Bao, W; Basolo, F; Bottici, V; Brandan, NC; Cappagli, V; Casella, F; Ciampi, R; Colavita, JP; Elisei, R; Espada, JD; Eugene, AR; He, D; Hinkle, SN; Hu, Z; Kalish, F; Lerman, DA; Materazzi, G; Matrone, A; Mendola, P; Piaggi, P; Prasad, S; Rodríguez, JP; Romei, C; Stevenson, DK; Stoyanoff, TR; Tacito, A; Todaro, JS; Torregrossa, L; Torres, AM; Tsai, MY; Ugolini, C; Valerio, L; Viola, D; Vitti, P; Wang, W; Wong, RJ; Xiao, J; Xie, M; Zhang, C; Zhang, H; Zhao, H; Zhu, Y | 1 |
| Bates, SE; Holbeck, SL; Kohlhagen, G; Medina-Perez, W; Mertins, SD; Myers, TG; Pommier, Y; Wang, E | 1 |
| Baisch, H; Fack, H; Hatje, U; Otto, U | 1 |
| Baisch, H; Otto, U | 1 |
| Everitt, JI; Goldsworthy, TW; Walker, CL; Wolf, DC | 1 |
| Blijham, GH; Damen, CA; Griffioen, AW; Groenewegen, G; Hellwig, SM; van Adrichem, NP | 1 |
| Laukkanen, MO; Naarala, J; Pulkkanen, KJ; Yla-Herttuala, S | 1 |
| Alley, M; Bates, SE; Bodde, E; Dykes, D; Gupta, R; Hollingshead, M; Jefferis, CA; Linehan, WM; Mertins, SD; Myers, TG; Tsai, P | 1 |
| Hiasa, Y; Konishi, N; Nakamura, T; Nakaoka, S; Nishii, K; Ohshima, M | 1 |
| Baba, S; Deguchi, N; Hata, M; Jitsukawa, S; Tachibana, M; Tazaki, H | 1 |
| Göhde, W; Hemmer, J; Kleinhans, G; Langer, EM | 1 |
11 other study(ies) available for bromodeoxyuridine and Adenocarcinoma Of Kidney
| Article | Year |
|---|---|
Topics: Adult; Aged; Aged, 80 and over; Animals; Antigens, Ly; Apoptosis; Astrocytes; Biomarkers; Biomarkers, Tumor; Blotting, Western; Bone Marrow Cells; Brain Ischemia; Bromodeoxyuridine; Carcinoma, Renal Cell; Case-Control Studies; Cell Hypoxia; Cell Movement; Cell Proliferation; Cells, Cultured; Chemokines; Diabetes, Gestational; Down-Regulation; Erythropoietin; Female; Gestational Age; Glucose; Heme Oxygenase-1; Heterozygote; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immunoenzyme Techniques; Insulin-Like Growth Factor Binding Protein 1; Insulin-Like Growth Factor Binding Protein 2; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Kidney Neoplasms; Longitudinal Studies; Male; Mice, Inbred C57BL; Mice, Knockout; Middle Aged; Mitogen-Activated Protein Kinases; Myeloid Cells; Neoplasm Grading; Neoplasm Staging; Neuroprotection; Odds Ratio; Oxidation-Reduction; Oxygen; Pregnancy; Prognosis; Rats; Real-Time Polymerase Chain Reaction; Receptors, CCR2; Receptors, Erythropoietin; Receptors, Granulocyte-Macrophage Colony-Stimulating Factor; Reverse Transcriptase Polymerase Chain Reaction; Risk Factors; RNA, Messenger; Signal Transduction; Stearoyl-CoA Desaturase; Survival Rate; TRPV Cation Channels; Tumor Cells, Cultured; Uterus; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; Young Adult | 2016 |
In vitro evaluation of dimethane sulfonate analogues with potential alkylating activity and selective renal cell carcinoma cytotoxicity.
Topics: Alkylating Agents; Animals; Bromodeoxyuridine; Busulfan; Carcinoma, Renal Cell; Carmustine; Cell Cycle; DNA Damage; Drug Evaluation, Preclinical; Drug Resistance, Neoplasm; Humans; Inhibitory Concentration 50; Kidney Neoplasms; Mesylates; Rats; Tumor Suppressor Protein p53; Yeasts | 2004 |
Heterogeneous cell kinetics in tumors analyzed with a simulation model for bromodeoxyuridine single and multiple labeling.
Topics: Animals; Bromodeoxyuridine; Carcinoma, Renal Cell; Cell Cycle; Cell Division; Cell Movement; Computer Simulation; DNA; Genetic Heterogeneity; Humans; Kidney; Mice; Mice, Nude; Neoplasm Transplantation; S Phase; Transplantation, Heterologous; Tumor Cells, Cultured | 1995 |
Intratumoral heterogeneity of S phase transition in solid tumours determined by bromodeoxyuridine labelling and flow cytometry.
Topics: Animals; Antimetabolites; Bromodeoxyuridine; Carcinoma, Renal Cell; Cell Movement; Flow Cytometry; Humans; Kidney Neoplasms; Mice; Mice, Nude; Models, Biological; Neoplasm Transplantation; Propidium; S Phase; Transplantation, Heterologous | 1993 |
Altered expression of transforming growth factor-alpha: an early event in renal cell carcinoma development.
Topics: Animals; Bromodeoxyuridine; Carcinoma, Renal Cell; Cell Division; Epithelial Cells; Epithelium; Kidney Neoplasms; Kidney Tubules; Phenotype; Precancerous Conditions; Rats; Rats, Inbred Strains; Transforming Growth Factor alpha | 1997 |
Endothelial CD34 is suppressed in human malignancies: role of angiogenic factors.
Topics: Antibodies; Antigens, CD34; Bromodeoxyuridine; Carcinoma, Renal Cell; Cell Division; E-Selectin; Endothelial Growth Factors; Endothelium, Vascular; Fibroblast Growth Factor 2; Flow Cytometry; Humans; Hyaluronan Receptors; Intercellular Adhesion Molecule-1; Kidney; Kidney Neoplasms; Lymphokines; Platelet Endothelial Cell Adhesion Molecule-1; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 1997 |
False-positive apoptosis signal in mouse kidney and liver detected with TUNEL assay.
Topics: Animals; Apoptosis; Bromodeoxyuridine; Carcinoma, Renal Cell; Caspase 3; Caspases; Cell Division; DNA; DNA Fragmentation; False Positive Reactions; Hepatocytes; Humans; In Situ Nick-End Labeling; Kidney; Kidney Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Sensitivity and Specificity; Spleen; Testis; Tumor Cells, Cultured | 2000 |
Screening for and identification of novel agents directed at renal cell carcinoma.
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bromodeoxyuridine; Carcinoma, Renal Cell; Cell Cycle; Cell Division; Cell Survival; Drug Design; Genes, p53; Genotype; Humans; Inhibitory Concentration 50; Kidney Neoplasms; Leukemia; Maximum Tolerated Dose; Mice; Models, Chemical; Neoplasm Transplantation; Time Factors; Tumor Cells, Cultured | 2001 |
Promoting effects of potassium dibasic phosphate on early-stage renal carcinogenesis in unilaterally nephrectomized rats treated with N-ethyl-N-hydroxyethylnitrosamine.
Topics: Animals; Body Weight; Bromodeoxyuridine; Carcinogens; Carcinoma, Renal Cell; Copper; Copper Sulfate; Diethylnitrosamine; Drug Synergism; Electrolytes; Hyperplasia; Kidney; Kidney Neoplasms; Male; Nephrectomy; Organ Size; Phosphates; Potassium; Potassium Compounds; Rats; Rats, Inbred Strains | 1992 |
Bromodeoxyuridine and deoxyribonucleic acid bivariate analysis in human renal cell carcinoma. Does flow cytometric determination predict malignant potential or prognosis of patients with renal cell carcinoma?
Topics: Bromodeoxyuridine; Carcinoma, Renal Cell; DNA, Neoplasm; Flow Cytometry; Humans; Kidney Neoplasms; Neoplasm Staging; Ploidies; Prognosis | 1992 |
The applications of the BrdUrd-technique for the estimation of cycling S-phase cells in human renal cell carcinoma.
Topics: Bromodeoxyuridine; Carcinoma, Renal Cell; Flow Cytometry; Humans; In Vitro Techniques; Interphase; Kidney Neoplasms; Mitotic Index; Tumor Cells, Cultured | 1988 |